Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Zinc suppresses Stat3-driven IL-6 production in primary mouse adipocytes

Chung H., Eom J., Damen MS., Stankiewicz TE., Sawada K., Alarcon PC.

Animal Study on Chronic Inflammation, published in Front Immunol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Front Immunol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41737207
PMCID
PMC12926143
DOI
10.3389/fimmu.2026.1714168

Abstract (original English)

Uncontrolled inflammatory cytokine production promotes pathogenesis of various chronic diseases. Zinc (Zn) regulates immune cell inflammatory cytokine production. However, the influence of Zn on the inflammatory properties of non-immune cells known to contribute to disease pathogenesis is not well understood. Adipocytes respond to various immunological stimuli by activating inflammatory pathways and secreting inflammatory cytokines. Here, we investigated the impact of Zn on adipocyte inflammatory vigor. We show that treatment of primary mouse adipocytes with Zn, in the form of Zn pyrithione, restricted their toll-like receptor ligand-driven IL-6 production. Mechanistically, IL-6 secreted from adipocytes functions in an autocrine fashion to activate the Stat3 pathway and amplify IL-6 production via a positive feedback loop. Notably, Zn treatment of adipocytes suppressed Stat3 signaling activation to break the positive feedback loop and subsequent expression of IL-6 and its receptor genes ( Il6st , Il6ra ). Collectively, our findings uncover a novel inhibitory role for Zn in non-immune cell, specifically adipocyte, IL-6 production. These findings invoke a potential role of Zn in the regulation of adipocyte-associated chronic inflammation and disease pathogenesis.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedAdipocytesAnimalsMiceZincReceptors, Interleukin-6Interleukin-6Signal TransductionSTAT3 Transcription FactorCytokine Receptor gp130

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research